Canada's #1 Source for Research Peptides|Canadian Based Peptide Supplier|Ships from British Columbia, Canada|International Shipping Available|Lab Verified|>99% Purity Guarantee|Same Day Shipping|Batch-Specific COAs|Canada's #1 Source for Research Peptides|Canadian Based Peptide Supplier|Ships from British Columbia, Canada|International Shipping Available|Lab Verified|>99% Purity Guarantee|Same Day Shipping|Batch-Specific COAs|Canada's #1 Source for Research Peptides|Canadian Based Peptide Supplier|Ships from British Columbia, Canada|International Shipping Available|Lab Verified|>99% Purity Guarantee|Same Day Shipping|Batch-Specific COAs|Canada's #1 Source for Research Peptides|Canadian Based Peptide Supplier|Ships from British Columbia, Canada|International Shipping Available|Lab Verified|>99% Purity Guarantee|Same Day Shipping|Batch-Specific COAs|
Regulatory

How Volta Reviews What It Publishes

Volta sells the compounds it writes about, and no editorial process removes that conflict. What a process can do is make the content checkable by someone who does not trust us. The named reviewer, the source rules, and what the purity figures mean.

Marcus Hopkin, PhD, Director of Research and Development at Volta Peptides.

Reviewed by Marcus Hopkin, PhD

Director of Research and Development, Volta Peptides

Written by Volta Peptides Editorial Team · Reviewed September 15, 2026

May 12, 2026Updated September 25, 20264 min read
How Volta Reviews What It Publishes

Key Takeaways

  • •>99% by HPLC is a specification. It is a release threshold Volta sets. It is a promise about what ships, not a measurement of any particular vial.
  • •A certificate figure is a measurement. A named laboratory reported it for one named lot, on a document with a report number.
  • •An industry norm quoted in teaching copy is neither, and belongs only where it is explaining the difference.

How Volta Reviews What It Publishes

Volta sells the compounds it writes about. That is a conflict of interest, it applies to every page on this site without exception, and no editorial process removes it. What a process can do is make the content checkable by someone who does not trust us, which is the only standard worth claiming. This is how that works in practice.

The review is internal, and that is stated rather than dressed up

Scientific and technical content is reviewed by Marcus Hopkin, PhD, Volta's Director of Research and Development, who holds a doctorate in organic chemistry and more than twelve years of analytical chemistry experience.

He is an employee. His review is internal scientific and technical review by someone the company pays. It is not peer review, it is not independent third-party review, and it is not medical review. Those three phrases describe things that are not happening here, and no page on this site may use them to describe this process.

He is also named as the reviewer of the articles he is credited on, not as their author. A reviewer credit and an author credit are different claims, and running them together is the easiest way for a byline to say something untrue.

Sources come before prose

The source rules are published in full at source selection. In short: primary literature and trial registries first, secondary sources cross-checked against primary ones, and a claim with nothing behind it does not get written.

Where an article reports a figure from a clinical trial, it reports what investigators administered in that named study. It is never reframed as guidance. Volta publishes no dosing, administration or protocol guidance for any material it lists, and an article that reads like a protocol has failed review regardless of how well sourced it is.

In-vitro, animal and human evidence are kept apart. A result in a cell line is not a result in a person, and collapsing the three is the most common way peptide writing goes wrong.

Corrections are published, not quietly edited

The corrections policy sets out what earns a visible notice and what earns a withdrawal. It names the episode where this site published articles under invented author names, because the false version was live long enough to have been read.

A page that was wrong and is now right, with no record that it changed, asks the reader to trust the current version on exactly the evidence that failed last time.

Melanotan II 10mg
In Stock

Melanotan II 10mg

10mg

$28 USD
MOTS-C 10mg
In Stock

MOTS-C 10mg

10mg

$28 USD
Retatrutide 10mg
In Stock

Retatrutide 10mg

10mg

Batch purity 99.7%· 20mg lot
$52 USD

What the purity figures mean

Three numbers appear on this site and they answer different questions.

  • >99% by HPLC is a specification. It is a release threshold Volta sets. It is a promise about what ships, not a measurement of any particular vial.
  • A certificate figure is a measurement. A named laboratory reported it for one named lot, on a document with a report number.
  • An industry norm quoted in teaching copy is neither, and belongs only where it is explaining the difference.

Presenting the first as the second is the specific dishonesty this vocabulary exists to prevent.

Testing is third-party, and coverage is not complete

Batch certificates are produced by an external analytical laboratory that Volta pays for testing. That is the ordinary commercial relationship between a supplier and its lab, it is disclosed on every certificate, and each certificate carries the laboratory's own verification link so a reader can confirm the result against the lab rather than against us.

Certificates are published at certificates of analysis as page images rather than source files. Most of the catalogue does not yet carry one. The quality page and the testing methodology state the coverage as it is, because a page implying every SKU is certified when most are not would undo the point of publishing any of them.

Every product page also prints a batch number derived from the compound and the vial strength. The lot number on a certificate is transcribed from the document. The two are produced independently, so comparing them is a real check a reader can run without trusting either of us.

Where the rest of it is written down

The full editorial process is at editorial standards. Sourcing is at source selection. Corrections are at corrections. Analytical methods are at testing methodology. Everyone credited on this site is listed at contributors.

All content here is for laboratory research and educational purposes. It is not medical advice, and nothing described is offered for human or veterinary use.

Research Use Only. This article is provided for informational and educational purposes only. The compounds and topics discussed are intended solely for laboratory and scientific research. This content does not constitute medical advice, and Volta Peptides does not endorse or promote human consumption of any research compound.

About the reviewer

Marcus Hopkin, PhD, Director of Research and Development at Volta Peptides.

Marcus Hopkin, PhD

Director of Research and Development, Volta Peptides

Marcus Hopkin, PhD, is Director of Research and Development at Volta Peptides. He has more than 12 years of analytical chemistry experience, including direct laboratory work in peptide synthesis, characterization, purity testing and stability assessment. His doctoral research at the University of Michigan examined novel peptide structures in the human proteome and their potential significance for therapeutic-peptide research. Before joining Volta Peptides he held research and development roles at Amgen and Eli Lilly and Company, and served as a lecturer at the University of Michigan.

Marcus reviewed this article for scientific and analytical accuracy on September 15, 2026. He did not write it. Technical review is internal review and is not peer review, independent third-party review or medical review.

Disclosure. Marcus Hopkin is an employee of Volta Peptides and serves as its Director of Research and Development. Volta Peptides sells research compounds related to subjects discussed in the content he writes and reviews. His reviews are internal scientific and technical review and must not be described as independent third-party review, peer review or medical review.

Shop Research Peptides

Melanotan II 10mg
In Stock

Melanotan II 10mg

10mg

$28 USD
MOTS-C 10mg
In Stock

MOTS-C 10mg

10mg

$28 USD
Retatrutide 10mg
In Stock

Retatrutide 10mg

10mg

Batch purity 99.7%· 20mg lot
$52 USD
Retatrutide 20mg
In Stock

Retatrutide 20mg

20mg

Batch purity 99.7%
$79 USD
Semaglutide 10mg
In Stock

Semaglutide 10mg

10mg

$29.59 USD
Semaglutide 20mg
In Stock

Semaglutide 20mg

20mg

$43.86 USD
Sermorelin 10mg
In Stock

Sermorelin 10mg

10mg

$63.11 USD
SS-31 10mg
In Stock

SS-31 10mg

10mg

$40 USD
TB-500 10mg
In Stock

TB-500 10mg

10mg

$54 USD

Peptide Tools

Your Cart

Your cart is empty

Browse our catalog to add research compounds.